ChemoCentryx Net Profit Margin 2009-2019 | CCXI

ChemoCentryx net profit margin from 2009 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
ChemoCentryx Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-06-30 $0.03B $-0.05B -148.48%
2019-03-31 $0.04B $-0.04B -100.00%
2018-12-31 $0.04B $-0.04B -88.37%
2018-09-30 $0.09B $0.01B 14.44%
2018-06-30 $0.09B $0.02B 18.89%
2018-03-31 $0.08B $0.02B 17.86%
2017-12-31 $0.08B $0.02B 21.95%
2017-09-30 $0.03B $-0.03B -96.77%
2017-06-30 $0.03B $-0.03B -115.38%
2017-03-31 $0.02B $-0.03B -155.00%
2013-12-31 $0.01B $-0.04B -557.14%
2013-09-30 $0.01B $-0.04B -487.50%
2013-06-30 $0.01B $-0.04B -571.43%
2013-03-31 $0.01B $-0.04B -683.33%
2012-12-31 $0.01B $-0.04B -800.00%
2012-09-30 $0.03B $-0.01B -41.38%
2012-06-30 $0.03B $-0.01B -37.93%
2012-03-31 $0.03B $-0.01B -27.59%
2011-12-31 $0.03B $-0.01B -16.13%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.410B $0.043B
ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.196B 37.07
Astellas Pharma (ALPMY) Japan $26.780B 13.13
Takeda Pharmaceutical (TAK) Japan $26.201B 8.18
Grifols, S.A (GRFS) Spain $15.161B 19.34
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.716B 25.30
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.973B 21.51
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.886B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Sage Therapeutics (SAGE) United States $8.507B 0.00
Catalent (CTLT) United States $8.127B 32.61
Jazz Pharmaceuticals (JAZZ) Ireland $7.726B 10.17
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.954B 17.81
FibroGen (FGEN) United States $3.877B 96.98
United Therapeutics (UTHR) United States $3.565B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.140B 11.25
Evotec AG (EVTCY) Germany $3.032B 41.51
Nektar Therapeutics (NKTR) United States $2.999B 0.00
Tilray (TLRY) Canada $2.849B 0.00
PTC Therapeutics (PTCT) United States $2.695B 0.00
Xencor (XNCR) United States $2.309B 50.35
Zogenix (ZGNX) United States $2.148B 0.00
Portola Pharmaceuticals (PTLA) United States $1.974B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.491B 14.95
Corcept Therapeutics (CORT) United States $1.468B 20.17
Heron Therapeutics (HRTX) United States $1.437B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.424B 23.49
Ironwood Pharmaceuticals (IRWD) United States $1.380B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.218B 0.00
ArQule (ARQL) United States $1.110B 0.00
Radius Health (RDUS) United States $1.059B 0.00
Aerie Pharmaceuticals (AERI) United States $1.034B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.919B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.828B 3.69
Endo (ENDP) Ireland $0.684B 1.20
TherapeuticsMD (TXMD) United States $0.661B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.636B 0.00
Indivior (INVVY) United States $0.575B 2.08
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
Akebia Therapeutics (AKBA) United States $0.534B 0.00
Dermira (DERM) United States $0.482B 0.00
Concordia (CXRXF) Canada $0.479B 0.00
Aptorum Group (APM) China $0.464B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.457B 0.00
Translate Bio (TBIO) United States $0.443B 0.00
Dova Pharmaceuticals (DOVA) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
ImmunoGen (IMGN) United States $0.409B 0.00
Flexion Therapeutics (FLXN) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.95
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
CV Sciences (CVSI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.323B 0.00
Xeris Pharmaceuticals (XERS) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.290B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.280B 0.00
CannTrust Holdings (CTST) Canada $0.277B 0.00
Lannett Co Inc (LCI) United States $0.277B 2.69
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
DURECT (DRRX) United States $0.263B 0.00
OptiNose (OPTN) United States $0.263B 0.00
Recro Pharma (REPH) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 29.26
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.155B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Generex Biotechnology (GNBT) United States $0.137B 0.00
Majesco Entertainment (PTE) United States $0.133B 0.00
Jounce Therapeutics (JNCE) United States $0.123B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
MEI Pharma (MEIP) United States $0.120B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.114B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.111B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
Cardiome Pharma (CORV) Canada $0.097B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.94
Genocea Biosciences (GNCA) United States $0.083B 0.00
MediWound (MDWD) Israel $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.078B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
Otonomy (OTIC) United States $0.072B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 589.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Capnia (SLNO) United States $0.060B 0.00
Lipocine (LPCN) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
CTI BioPharma (CTIC) United States $0.040B 0.00
Aclaris Therapeutics (ACRS) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Melinta Therapeutics (MLNT) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
IsoRay (ISR) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.44
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00